2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
FDA Comment Number : EC139
Submitter : Mr. V. Lindy Spassenko Date & Time: 12/07/2005 06:12:16
Organization : Mr. V. Lindy Spassenko
Category : Drug Industry
Issue Areas/Comments
SSRI recommendations from the drug industry are based on false data about mental illness, with no proven results, and no scientivic evidence. Advertising such products is a severe breach of ethics and should not be allowed.